Economic evaluation of monoclonal antibody in the management of colorectal cancer in Malaysia
Saved in:
Main Authors: | Natrah MS (Author), Ezat WP Sharifa (Author), Syed MA (Author), Rizal Mohd AM (Author), Saperi S (Author), Ismail S (Author), Fuad I (Author), Azrif Muhd MA (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost analysis of colorectal cancer (CRC) management in UKM Medical Centre using clinical pathway
by: Mohd Natrah, et al.
Published: (2012) -
Predicting patients' arrival to the Emergency Department UKMMC
by: Majid Noriza, et al.
Published: (2012) -
A comparative study of cost and quality of life among Skeletal Related Events (SRE) and non-SRE among breast and prostate cancer patients in Malaysia
by: Khamis Noraziani, et al.
Published: (2012) -
Development of ICD 11: changes and challenges
by: Zafar A, et al.
Published: (2012) -
Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies
by: Françoso A, et al.
Published: (2017)